Paper · 40927382
CRISPR and gene editing for kidney diseases: where are we?
D'Ambrosio V and 6 others. Clin Kidney J, 2025. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. CRISPR and gene editing for kidney diseases: where are we? Papers, record 40927382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40927382
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 AI176460 | NIAID NIH HHS | United States | U01AI176460 | PubMed | NIH RePORTER |
| U2C TR004867 | NCATS NIH HHS | United States | U2CTR004867 | PubMed | NIH RePORTER |
| U54 DK144864 | NIDDK NIH HHS | United States | U54DK144864 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,009,235 | Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. | J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/24009235 | PubMed |
| 2 | 11,786,991 | Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution. | Am J Phys Anthropol | 2001 | https://conductscience.org/library/papers/11786991 | PubMed |
| 3 | 38,290,599 | Physiologic homeostasis after pig-to-human kidney xenotransplantation. | Kidney Int | 2024 | https://conductscience.org/library/papers/38290599 | PubMed |
| 4 | 36,610,723 | Trends in kidney transplantation rate across Europe: study from the ERA Registry. | Nephrol Dial Transplant | 2023 | https://conductscience.org/library/papers/36610723 | PubMed |
| 5 | 37,646,679 | CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37646679 | PubMed |
| 6 | 34,480,847 | Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. | Mol Cell | 2021 | https://conductscience.org/library/papers/34480847 | PubMed |
| 7 | 25,339,675 | Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease. | J Immunol | 2014 | https://conductscience.org/library/papers/25339675 | PubMed |
| 8 | 11,152,095 | The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. | Transplantation | 2000 | https://conductscience.org/library/papers/11152095 | PubMed |
| 9 | 35,478,224 | Modelling ciliopathy phenotypes in human tissues derived from pluripotent stem cells with genetically ablated cilia. | Nat Biomed Eng | 2022 | https://conductscience.org/library/papers/35478224 | PubMed |
| 10 | 27,392,076 | Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia. | Am J Hum Genet | 2016 | https://conductscience.org/library/papers/27392076 | PubMed |
1 to 10 of 87
See all 87 referencesCited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,676,846 | New Dimensions in Diabetic Kidney Disease Research: Advanced Organoids and Organs-on-a-Chip. | BME Front | 2026 | https://conductscience.org/library/papers/42676846 | PubMed |
| 42,606,777 | Targeting the lncRNA PVT-1-Hippo signaling axis in kidney diseases: an emerging therapeutic paradigm. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42606777 | PubMed |
| 42,553,915 | Therapeutic Applications of Induced Pluripotent Stem Cell Technology in Kidney Disease: A Systematic Review and Meta-Analysis. | Kidney Dis (Basel) | 2026 | https://conductscience.org/library/papers/42553915 | PubMed |
| 42,402,511 | New therapeutic hope for rare podocytopathies. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/42402511 | PubMed |
| 42,356,544 | The Role and Therapeutic Potential of the STING Signaling Pathway in the Pathogenesis of Diabetic Nephropathy. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42356544 | PubMed |
| 42,203,913 | The anti-interleukin-6 antibody ALD518-P18 mitigates murine kidney ischemia-reperfusion injury. | Sci Rep | 2026 | https://conductscience.org/library/papers/42203913 | PubMed |
| 42,193,072 | Advances in the Treatment of Autosomal Dominant Polycystic Kidney Disease and Novel Therapeutic Targets. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42193072 | PubMed |
| 41,897,393 | Dose-Dependent and Non-Autonomous Signaling in CAKUT: A Lineage-Specific Framework from Conditional Knockout Studies. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897393 | PubMed |
| 41,554,351 | Gene modification: Exploring the potential in treating kidney diseases. | Pharmacol Res | 2026 | https://conductscience.org/library/papers/41554351 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40927382
GET https://conductscience.org/api/papers/v1/40927382/references?page=2